Physician profile
Yulin Chen
NPI 1104226919
$1,100.81
in general payments reported to CMS, 2019-2025
16 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.13 · 2022: $164 · 2023: $306 · 2024: $271 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.84 | 2021-2024 | Jardiance |
| Abiomed | $139.47 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $118.33 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.55 | 2022-2025 | Lifevest |
| Medtronic, INC. | $73.55 | 2022-2024 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $73.18 | 2022-2025 | Ensite, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $62.46 | 2022-2024 | Wainua, Brilinta |
| Stryker Corporation | $58.47 | 2023-2024 | N/A |
| Novartis Pharmaceuticals Corporation | $51.70 | 2023-2024 | |
| Pfizer INC. | $43.41 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $43.09 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $41.92 | 2023-2024 | Ozempic, Rybelsus |
| Livanova USA, INC. | $23.82 | 2023 | Tandemlife |
| Alnylam Pharmaceuticals INC. | $22.85 | 2025 | Onpattro |
| Boston Scientific Corporation | $16.73 | 2025 | Avvigo Guidance System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yulin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.